• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质冠:复杂体外环境中淋巴与血液的影响。

Protein Corona: Impact of Lymph Versus Blood in a Complex In Vitro Environment.

机构信息

Powder Technology Laboratory, Institute of Materials, Ecole polytechnique fédérale de Lausanne, EPFL STI IMX LTP, Station 12, 1015, Lausanne, Switzerland.

Department of Chemistry and Biochemistry, University of Bern, N431, Freiestrasse 3, 3012, Bern, Switzerland.

出版信息

Small. 2017 Aug;13(29). doi: 10.1002/smll.201700409. Epub 2017 Jun 5.

DOI:10.1002/smll.201700409
PMID:28582610
Abstract

In biological environments, the surface of nanoparticles (NPs) are modified by protein corona (PC) that determines their biological behavior. Unfortunately, in vitro tests still give different PC than in vivo tests causing in vitro-in vivo discrepancy; hence, in vitro studies are not indicative for the NPs' behavior in vivo. Here is demonstrated that PC in vitro is strongly influenced by the type of extracellular fluid (ECF), blood or lymph, by their high and low flow conditions and transitions between ECFs, and a combination of these parameters. As a result, this in vitro study approaches fluidic and dynamic variations to which NPs are exposed in vivo: different ECF that NPs encounter first in different injection routes, different transitions in-between ECFs during circulation, and simultaneous change in the exposed flow in these transitions. The most-abundant proteins in PCs are found to be not the most abundant in ECFs, but those having high affinity for binding to the surface of NPs. Moreover, some proteins are differently abundant in PCs at different flows, which indicate force-promoted binding, catch bonds. These results suggest that future in vitro studies should consider more complex incubation conditions to improve the in vitro-in vivo consistency necessary for translational research.

摘要

在生物环境中,纳米粒子(NPs)的表面会被蛋白质冠(PC)修饰,这决定了它们的生物行为。不幸的是,体外测试得到的 PC 与体内测试不同,导致了体外-体内差异;因此,体外研究并不能说明 NPs 在体内的行为。本研究表明,PC 在体外强烈受到细胞外液(ECF)类型、血液或淋巴、高和低流速条件以及 ECF 之间的转换以及这些参数的组合的影响。因此,这项体外研究接近了 NPs 在体内暴露的流体动力学和动态变化:不同的 ECF,NPs 首先通过不同的注射途径接触,在循环过程中 ECF 之间的不同转换,以及这些转换中暴露流的同时变化。在 PCs 中最丰富的蛋白质不是 ECF 中最丰富的蛋白质,而是那些与 NPs 表面具有高亲和力的蛋白质。此外,一些蛋白质在不同的流速下在 PCs 中的丰度不同,这表明存在力促进结合的黏附键。这些结果表明,未来的体外研究应考虑更复杂的孵育条件,以提高转化研究所需的体外-体内一致性。

相似文献

1
Protein Corona: Impact of Lymph Versus Blood in a Complex In Vitro Environment.蛋白质冠:复杂体外环境中淋巴与血液的影响。
Small. 2017 Aug;13(29). doi: 10.1002/smll.201700409. Epub 2017 Jun 5.
2
Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells.动态流动环境对纳米颗粒-蛋白质冠层的影响:从蛋白质模式到癌细胞摄取
Colloids Surf B Biointerfaces. 2017 May 1;153:263-271. doi: 10.1016/j.colsurfb.2017.02.037. Epub 2017 Feb 28.
3
The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.纳米颗粒-蛋白冠复合物与细胞的相互作用及其对细胞的毒性作用。
Chemosphere. 2020 Apr;245:125624. doi: 10.1016/j.chemosphere.2019.125624. Epub 2019 Dec 12.
4
Protein corona and nanoparticles: how can we investigate on?蛋白质冠和纳米颗粒:我们如何进行研究?
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Nov;9(6). doi: 10.1002/wnan.1467. Epub 2017 Mar 15.
5
How protein coronas determine the fate of engineered nanoparticles in biological environment.蛋白质冠层如何决定工程纳米颗粒在生物环境中的命运。
Arh Hig Rada Toksikol. 2017 Dec 20;68(4):245-253. doi: 10.1515/aiht-2017-68-3054.
6
Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part II: In vitro and in vivo Kinetics Study.纳米颗粒蛋白冠中的独特蛋白质代表了内源性靶向的有前途的靶标 - 第二部分:体外和体内动力学研究。
Int J Nanomedicine. 2020 Nov 30;15:9539-9556. doi: 10.2147/IJN.S273721. eCollection 2020.
7
The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum.为体外蛋白质冠层分析选择合适生物环境的重要性:人血浆与人血清的比较。
Int J Biochem Cell Biol. 2016 Jun;75:188-95. doi: 10.1016/j.biocel.2015.11.019. Epub 2015 Nov 28.
8
Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.胶态聚合物纳米粒子和聚合纳米凝胶上蛋白质冠的形成:对细胞摄取、毒性、免疫原性和药物释放性质的影响。
Biomacromolecules. 2017 Jun 12;18(6):1762-1771. doi: 10.1021/acs.biomac.7b00158. Epub 2017 May 26.
9
Impact of Surface-Engineered ZnO Nanoparticles on Protein Corona Configuration and Their Interactions With Biological System.表面工程 ZnO 纳米粒子对蛋白冠构象的影响及其与生物体系的相互作用。
J Pharm Sci. 2019 May;108(5):1872-1889. doi: 10.1016/j.xphs.2018.12.021. Epub 2019 Jan 5.
10
In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?纳米医学中的体外-体内相关性(IVIVC):蛋白质冠是缺失的环节吗?
Biotechnol Adv. 2017 Nov 15;35(7):889-904. doi: 10.1016/j.biotechadv.2017.08.003. Epub 2017 Aug 26.

引用本文的文献

1
Positron Emission Tomography-Based Pharmacokinetics of mRNA-Lipid Nanoparticles: A Study Quantifying the ApoE and Macrophage Contribution.基于正电子发射断层扫描的mRNA-脂质纳米颗粒药代动力学:一项量化载脂蛋白E和巨噬细胞贡献的研究。
ACS Appl Mater Interfaces. 2025 Aug 13;17(32):45625-45639. doi: 10.1021/acsami.5c14143. Epub 2025 Aug 3.
2
The Challenges and Opportunities of Protein Coronas for Nanoscale Biomolecular Sensing.蛋白质冠层在纳米级生物分子传感中的挑战与机遇
Small. 2025 Sep;21(36):e03820. doi: 10.1002/smll.202503820. Epub 2025 Jul 26.
3
Investigation of the protein corona and biodistribution profile of polymeric nanoparticles for intra-amniotic delivery.
用于羊膜腔内给药的聚合物纳米颗粒的蛋白质冠层和生物分布概况研究。
Biomaterials. 2025 Sep;320:123238. doi: 10.1016/j.biomaterials.2025.123238. Epub 2025 Mar 6.
4
Comprehensive and deep profiling of the plasma proteome with protein corona on zeolite NaY.用沸石NaY上的蛋白质冠对血浆蛋白质组进行全面深入的分析。
J Pharm Anal. 2023 May;13(5):503-513. doi: 10.1016/j.jpha.2023.04.002. Epub 2023 Apr 12.
5
Macromolecules Absorbed from Influenza Infection-Based Sera Modulate the Cellular Uptake of Polymeric Nanoparticles.从流感感染血清中吸收的大分子调节聚合物纳米颗粒的细胞摄取。
Biomimetics (Basel). 2022 Nov 30;7(4):219. doi: 10.3390/biomimetics7040219.
6
Isolation methods for particle protein corona complexes from protein-rich matrices.从富含蛋白质的基质中分离颗粒蛋白冠复合物的方法。
Nanoscale Adv. 2020 Jan 9;2(2):563-582. doi: 10.1039/c9na00537d. eCollection 2020 Feb 18.
7
protein corona on nanoparticles: does the control of all material parameters orient the biological behavior?纳米颗粒上的蛋白质冠层:所有材料参数的控制是否能引导生物学行为?
Nanoscale Adv. 2021 Jan 13;3(5):1209-1229. doi: 10.1039/d0na00863j. eCollection 2021 Mar 9.
8
Progress and Hurdles of Therapeutic Nanosystems against Cancer.治疗性纳米系统对抗癌症的进展与障碍
Pharmaceutics. 2022 Feb 10;14(2):388. doi: 10.3390/pharmaceutics14020388.
9
Recent Advances in Understanding the Protein Corona of Nanoparticles and in the Formulation of "Stealthy" Nanomaterials.纳米颗粒蛋白质冠层理解及“隐形”纳米材料制备的最新进展
Front Bioeng Biotechnol. 2020 Apr 3;8:166. doi: 10.3389/fbioe.2020.00166. eCollection 2020.
10
Improving nanotherapy delivery and action through image-guided systems pharmacology.通过图像引导系统药理学改善纳米治疗药物的传递和作用。
Theranostics. 2020 Jan 1;10(3):968-997. doi: 10.7150/thno.37215. eCollection 2020.